Nicole M. Ryan - Toxicology

Author Information

Nicole M. Ryan is a distinguished researcher affiliated with the Clinical Toxicology Research Group at The University of Newcastle, located in Newcastle, NSW, Australia. Her research primarily focuses on the field of toxicology, with a particular emphasis on clinical applications and health interventions. Her work often addresses issues relevant to public health, such as drug-related harms and the safety of medical therapies.

Research Contributions

Nicole M. Ryan has made significant contributions to the field of toxicology through her diverse research endeavors. Her studies cover a wide range of topics including the development of mobile health interventions for improving the well-being of Aboriginal and Torres Strait Islander women, smoking cessation strategies, and drug misuse trends in Australia. Notable works include her research on the safety of high-dose insulin euglycemia therapy in toxin-induced cardiac toxicity and the clinical effects of snake envenoming. Her research has been impactful in advancing knowledge in both clinical toxicology and public health.

Aliases

Nicole M. Ryan is also known by several aliases in academic publications, including N Ryan, Nicole Ryan, and Nicole M Ryan. These variations appear in different contexts within her published works.

Publication and Citation Metrics

Metric	Value
Total Papers	38
Citation Count	1518
H-index	19

Publications:

Codeveloping a multibehavioural mobile phone app to enhance social and emotional well-being and reduce health risks among Aboriginal and Torres Strait Islander women during preconception and pregnancy: a three-phased mixed-methods study

DOI: 10.1136/bmjopen-2021-052545

Year: 2021

Smoking Cessation Messages for Pregnant Aboriginal and Torres Strait Islander Women: A Rapid Review of Peer-Reviewed Literature and Assessment of Research Translation of Media Content

DOI: 10.3390/ijerph18179341

Year: 2021

Monitoring emerging prescription-drug related harms: a comment on Cairns et al. (2018)-in reply.

DOI: 10.1111/add.14531

Year: 2019

Low dose ketamine provides poor analgesia for pain in redback spider envenoming.

DOI: 10.1111/bcp.14052

Year: 2019

Rising pregabalin use and misuse in Australia: trends in utilization and intentional poisonings

DOI: 10.1111/add.14412

Year: 2019

IHI ID 01 Saving 414 bed days in FY18: discharge planning for patients with new tracheostomies

DOI: 10.1136/ihisciabs.1

Year: 2018

The safety of high-dose insulin euglycaemia therapy in toxin-induced cardiac toxicity

DOI: 10.1080/15563650.2017.1391391

Year: 2018

An update and systematic review on drug therapies for the treatment of refractory chronic cough

DOI: 10.1080/14656566.2018.1462795

Year: 2018

The Australian Snakebite Project, 2005–2015 (ASP‐20)

DOI: 10.5694/mja17.00094

Year: 2017

Australian taipan (Oxyuranus spp.) envenoming: clinical effects and potential benefits of early antivenom therapy – Australian Snakebite Project (ASP-25)

DOI: 10.1080/15563650.2016.1250903

Year: 2017

What is the Future of RoHS in Toxicology?

What Are the Challenges in Human Testing?

What Are the Health Risks Associated with Thermal Decomposition?

What are the Toxic Compounds in Datura Stramonium?

How Can Advances in Technology Improve Quantitative Toxicology?

How is BRCA1 Related to Toxicology?

What are the health effects of exposure to oily substances?

What Are the Toxicological Concerns of Polymer Degradation?

Who is Responsible for Ensuring GLP Compliance?

How Do Antioxidant Enzymes Work?

Partnered Content Networks

Relevant Topics